Guselkumab Induction Improves Moderate-to-Severe UC at Week 12 ...Middle East

Medscape - News
The drug was statistically superior to the placebo across all key endpoints in phase 2b study, regardless of patient response or intolerance to conventional and advanced therapies. MDedge News

Hence then, the article about guselkumab induction improves moderate to severe uc at week 12 was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Guselkumab Induction Improves Moderate-to-Severe UC at Week 12 )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News